{"schema_version":"1","generated_at":"2026-11-08T21:02:59.482Z","data_as_of":null,"url":"https://www.findmykol.com/kol/arash-velayati","json_url":"https://www.findmykol.com/kol/arash-velayati/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"arash-velayati","name":"Arash Velayati","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Sacramento","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1689093692","orcid":"0000-0002-7120-4532","openalex":"A5082988794"},"summary":"Arash Velayati is an Oncology physician. OpenAlex indexes 75 publications with 1,347 citations (h-index 17).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":75,"cited_by_count":1347,"h_index":17,"latest_activity_year":2026,"emerging":true,"source":"works"},"payments":{"company_count":14,"program_years":{"first":2021,"last":null},"rows_total":18,"shown":3,"withheld":15,"rows":[{"payer":"Secura Bio, Inc.","program_year":2025,"amount_usd":183.71,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1689093692"},{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":143.09,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1689093692"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":25.29,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1689093692"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1689093692","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy","year":2026,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-026-01474-2","status":"verified"},{"title":"Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025018527","status":"verified"},{"title":"Non-response to bridging therapy prior to CAR-T is associated with increased toxicity and adverse outcomes in Relapsed/Refractory multiple myeloma (RRMM)","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-4586","status":"verified"},{"title":"Rapid peak CAR-T expansion is associated with delayed neurotoxicity following ciltacabtagene autoleucel in multiple myeloma","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-96","status":"verified"},{"title":"Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohort","year":2025,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-025-01418-2","status":"verified"}],"source":"works"},"contact":{"address_1":"2279 45TH ST","city":"Sacramento","state":"CA","zip":"958171514","phone":"916-734-5959","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1689093692","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":15,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-08-14","provider_certified":"2025-08-14","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}